Psoriasis Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Funding
• Alerts
• Clinical Trials
• Forums

Topical Calcipotriol /Betamethasone Ointment in the Treatment of Plaque Psoriasis
Conditions:   Psoriasis Vulgaris;   Fractional CO2 Laser Interventions:   Drug: Topical Ointment containing Calcipotriol 0.05 mg/gm and Betamethasone dipropionate 0.5 mg/gm;   Device: Fractional carbon dioxide (CO2) laser Sponsor:   Assiut University Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 25, 2023 Category: Research Source Type: clinical trials

A Study to Evaluate the Efficacy and Safety of Bimekizumab in Chinese Adult Study Participants With Moderate to Severe Plaque Psoriasis
Conditions:   Chronic Plaque Psoriasis;   Moderate to Severe Chronic Plaque Psoriasis Interventions:   Other: Placebo;   Drug: Bimekizumab Sponsor:   UCB Biopharma SRL Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 25, 2023 Category: Research Source Type: clinical trials

Topical Calcipotriol /Betamethasone Ointment in the Treatment of Plaque Psoriasis
Conditions:   Psoriasis Vulgaris;   Fractional CO2 Laser Interventions:   Drug: Topical Ointment containing Calcipotriol 0.05 mg/gm and Betamethasone dipropionate 0.5 mg/gm;   Device: Fractional carbon dioxide (CO2) laser Sponsor:   Assiut University Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 25, 2023 Category: Research Source Type: clinical trials

A Study to Evaluate the Efficacy and Safety of Bimekizumab in Chinese Adult Study Participants With Moderate to Severe Plaque Psoriasis
Conditions:   Chronic Plaque Psoriasis;   Moderate to Severe Chronic Plaque Psoriasis Interventions:   Other: Placebo;   Drug: Bimekizumab Sponsor:   UCB Biopharma SRL Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 25, 2023 Category: Research Source Type: clinical trials

Topical Calcipotriol /Betamethasone Ointment in the Treatment of Plaque Psoriasis
Conditions:   Psoriasis Vulgaris;   Fractional CO2 Laser Interventions:   Drug: Topical Ointment containing Calcipotriol 0.05 mg/gm and Betamethasone dipropionate 0.5 mg/gm;   Device: Fractional carbon dioxide (CO2) laser Sponsor:   Assiut University Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 25, 2023 Category: Research Source Type: clinical trials

A Study to Evaluate the Efficacy and Safety of Bimekizumab in Chinese Adult Study Participants With Moderate to Severe Plaque Psoriasis
Conditions:   Chronic Plaque Psoriasis;   Moderate to Severe Chronic Plaque Psoriasis Interventions:   Other: Placebo;   Drug: Bimekizumab Sponsor:   UCB Biopharma SRL Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 25, 2023 Category: Research Source Type: clinical trials

Topical Calcipotriol /Betamethasone Ointment in the Treatment of Plaque Psoriasis
Conditions:   Psoriasis Vulgaris;   Fractional CO2 Laser Interventions:   Drug: Topical Ointment containing Calcipotriol 0.05 mg/gm and Betamethasone dipropionate 0.5 mg/gm;   Device: Fractional carbon dioxide (CO2) laser Sponsor:   Assiut University Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 25, 2023 Category: Research Source Type: clinical trials

A Study to Evaluate the Efficacy and Safety of Bimekizumab in Chinese Adult Study Participants With Moderate to Severe Plaque Psoriasis
Conditions:   Chronic Plaque Psoriasis;   Moderate to Severe Chronic Plaque Psoriasis Interventions:   Other: Placebo;   Drug: Bimekizumab Sponsor:   UCB Biopharma SRL Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 25, 2023 Category: Research Source Type: clinical trials

Topical Calcipotriol /Betamethasone Ointment in the Treatment of Plaque Psoriasis
Conditions:   Psoriasis Vulgaris;   Fractional CO2 Laser Interventions:   Drug: Topical Ointment containing Calcipotriol 0.05 mg/gm and Betamethasone dipropionate 0.5 mg/gm;   Device: Fractional carbon dioxide (CO2) laser Sponsor:   Assiut University Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 25, 2023 Category: Research Source Type: clinical trials

A Study to Evaluate the Efficacy and Safety of Bimekizumab in Chinese Adult Study Participants With Moderate to Severe Plaque Psoriasis
Conditions:   Chronic Plaque Psoriasis;   Moderate to Severe Chronic Plaque Psoriasis Interventions:   Other: Placebo;   Drug: Bimekizumab Sponsor:   UCB Biopharma SRL Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 25, 2023 Category: Research Source Type: clinical trials

Topical Calcipotriol /Betamethasone Ointment in the Treatment of Plaque Psoriasis
Conditions:   Psoriasis Vulgaris;   Fractional CO2 Laser Interventions:   Drug: Topical Ointment containing Calcipotriol 0.05 mg/gm and Betamethasone dipropionate 0.5 mg/gm;   Device: Fractional carbon dioxide (CO2) laser Sponsor:   Assiut University Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 25, 2023 Category: Research Source Type: clinical trials

A Study to Evaluate the Efficacy and Safety of Bimekizumab in Chinese Adult Study Participants With Moderate to Severe Plaque Psoriasis
Conditions:   Chronic Plaque Psoriasis;   Moderate to Severe Chronic Plaque Psoriasis Interventions:   Other: Placebo;   Drug: Bimekizumab Sponsor:   UCB Biopharma SRL Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 25, 2023 Category: Research Source Type: clinical trials

Topical Calcipotriol /Betamethasone Ointment in the Treatment of Plaque Psoriasis
Conditions:   Psoriasis Vulgaris;   Fractional CO2 Laser Interventions:   Drug: Topical Ointment containing Calcipotriol 0.05 mg/gm and Betamethasone dipropionate 0.5 mg/gm;   Device: Fractional carbon dioxide (CO2) laser Sponsor:   Assiut University Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 25, 2023 Category: Research Source Type: clinical trials

A Study to Evaluate the Efficacy and Safety of Bimekizumab in Chinese Adult Study Participants With Moderate to Severe Plaque Psoriasis
Conditions:   Chronic Plaque Psoriasis;   Moderate to Severe Chronic Plaque Psoriasis Interventions:   Other: Placebo;   Drug: Bimekizumab Sponsor:   UCB Biopharma SRL Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 25, 2023 Category: Research Source Type: clinical trials